Disease Areas

News and analysis on disease research and diagnostics.

Agilent, InterVenn to Partner on Clinical Glycoproteomic Analysis

The team plans to begin development work at InterVenn Malaysia's laboratory at Technology Park Malaysia in Kuala Lumpur.

Ymir Genomics Licenses Urine Biomarkers for Liver Disease Detection From OHSU

Ymir Genomics and OHSU will share in any value created by the biomarkers and will jointly publish and validate the biomarkers in a large-scale multi-center study.

Interpace Q2 Revenues Decline 14 Percent

For the three months ended June 30, the firm reported revenues of $5.4 million, down from $6.3 million in the year-ago quarter and missing the consensus Wall Street estimate of $5.9 million.

Centogene Increases Full-Year Revenue Guidance; CEO Resigns

The German diagnostics firm expects more than €80 million in 2020 revenues, driven by its recovering core business and its COVID-19 testing business.

CMS Colon Cancer Screening Memo Bodes Well for Assays in Development; Denies Epi ProColon

The agency issued a new draft decision memo, outlining various criteria it intends to apply when determining coverage for current and future blood-based CRC screening tests.

Oct 19, 2020

Fluidigm Shares Rise on Selection of Saliva-Based COVID-19 Assay for Federal Surge Testing

Oct 19, 2020

FDA Reissues Emergency Use Authorization for Thermo Fisher Scientific COVID-19 Combo Kit

Oct 19, 2020

LumiraDx Gets FDA Emergency Use Authorization for PCR-Based Coronavirus Test

Oct 19, 2020

Coronavirus Testing Specimen Collection Devices From DNA Genotek, Clinical Enterprises Get FDA EUAs

Oct 16, 2020

Interdisciplinary NIST Team Claims qPCR Improvements Using Unusual Math Tweaks

Premium

Oct 16, 2020

Disparity in Microsatellite Instability Testing Suggests Need to Close Socioeconomic Access Gaps

Premium

Oct 16, 2020

NGS-Based Profiling May Guide Treatment for Patients With Cancers of Unknown Primary

Oct 16, 2020

SARS-CoV-2 Protein Interaction Study Reveals Key Proliferation Pathways, Possible Drug Targets

Premium

Oct 16, 2020

Pancreatic Cancer Subtype With Poor Outcomes Shows Low Methylation, High Interferon Signature

Oct 15, 2020

Germany Grants National Reimbursement for Three Additional Breast Cancer Biomarker Tests

Oct 15, 2020

Scanogen Developing Direct-From-Blood Infection Test That Could Provide Results in 90 Minutes

Premium

Oct 15, 2020

Novacyt Acquires Instrument Manufacturer IT-IS for £10.1M

Oct 15, 2020

Roche Diagnostic Revenues Grow 2 Percent in First Nine Months of 2020

Oct 15, 2020

OpGen Posts 54 Percent Increase in Preliminary Q3 Revenues, Consolidates Product Portfolio

Oct 14, 2020

Developmental Disorder Study Identifies 28 Novel Disease Genes

Oct 14, 2020

Tempus Enters Infectious Disease Market With Large-Scale COVID-19 Testing, Data Initiative

Premium

Oct 14, 2020

Summit Biolabs, CCPM to Develop Liquid Biopsy Tests for COVID-19, Head and Neck Cancer

Oct 14, 2020

PerkinElmer to Provide Testing for BioMarin Program in Mexico

Oct 14, 2020

Inspirata Partners With Carebox Healthcare on Automated Cancer Clinical Trial Matching

Oct 14, 2020

PierianDx, Pillar Biosciences Partner to Streamline NGS Cancer Analysis

Breaking News

The Scan

UK Funds Challenge Trial

The UK is investing £33.6 million into a controversial human SARS-CoV-2 challenge study, according to Reuters.

Watching the Changes

The Guardian reports that the UK COVID genomics consortium is monitoring mutations that are arising within circulating SARS-CoV-2 strains for any that may affect future vaccines.

Max Planck, Nature Strike a Deal

Science reports that Max Planck and Nature have struck a deal for affiliated authors to publish papers that are accessible to the public as well as access Nature-branded journals.

PNAS Papers on Ancient Tibetan Animals, HNSCC Drug Response, More

In PNAS this week: genomic analysis of ancient animals from Tibet, oncoproteins tied to WEE1 kinase enzyme inhibitor response, and more.

Featured White Papers

Lessons on sample accessioning and processing at clinical labs during a pandemic

Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by Mass Spectrometry

Optimized Protocol for Sequencing the SARS-CoV-2 Genome A GenomeWeb eCase Study Transcript

Accelerate COVID-19 Research with New Insights from World-Class Proteomics

Nov

10

Featured Webinar

IVDR in Light of the COVID Pandemic: The Near Future of In Vitro Diagnostic Testing

The COVID-19 pandemic created a paradigm shift in modern healthcare, where regulations, protocols, and mindsets had to be reworked in just a matter of months to keep up with the pace of the virus.

Menu

Disease Areas